Searched for
PFIZER LAWSUIT
Pfizer to acquire obesity drug startup Metsera in $10 billion dealPfizer has agreed to acquire obesity drug developer Metsera for up to $86.25 a share, surpassing Novo Nordisk's final offer. This move mark...- Pfizer, Novo Nordisk escalate bidding war for obesity drug developer MetseraA fierce bidding war is underway for Metsera, an obesity drug developer. Novo Nordisk has made a $10 billion offer, which Metsera considers...
- Pfizer sues Metsera, Novo Nordisk over rival obesity drug bidPfizer sued Metsera and Novo Nordisk, alleging Metsera breached its merger agreement by deeming Novo's $8.5 billion bid superior. Pfizer se...
- GSK set to get $500 million from settlement of mRNA lawsuitCureVac NV has settled its US patent dispute with Pfizer and BioNTech SE regarding mRNA vaccines, resulting in GSK receiving up to $500 mil...
- AstraZeneca gets $107 mln Pfizer verdict overturned in US cancer drug patent fightOn Wednesday, U.S. District Judge Matthew Kennelly invalidated Pfizer’s patents related to the cancer drug Nerlynx, overturning a jury's $1...
- GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technologyGlaxoSmithKline (GSK) has filed a lawsuit against Pfizer and BioNTech in Delaware federal court, alleging infringement of GSK's patents rel...
- Drugmaker GSK settles another California lawsuit on heartburn drug ZantacGlaxoSmithKline (GSK) has announced that it will confidentially settle another lawsuit in California regarding its discontinued heartburn d...
- Moderna sues Pfizer/BioNTech for patent infringement over COVID vaccineModerna alleges Pfizer/BioNTech, without permission, copied mRNA technology that Moderna had patented between 2010 and 2016, well before CO...
- India may consider indemnity for Pfizer and Moderna vaccines on one condition
- Indemnity demand holding up Pfizer jab’s India approvalPfizer has signed an indemnity clause with many countries that are using its vaccine, absolving the company from paying any legal cost in c...
- Pfizer, Moderna may want indemnity cover before launching vaccine in IndiaThe Indian government on Tuesday had allowed granting emergency licence for vaccines that have been approved by the US, the UK, Europe, Jap...
- Pfizer loses prempro ruling, must pay $10.4 million: CourtPfizer must pay $10.4 million in damages to a woman who blamed the company’s Prempro menopause drug for her breast cancer.
- Ranbaxy and Pfizer sued for delay in launch of Lipitor in USA group of US pharmacies filed lawsuit against Ranbaxy, Pfizer & accused the two drug firms of delaying the launch of Lipitor in the US
- US court rejects Mylan plea against RanbaxyA US court has dismissed Mylan’s attempt to prevent Ranbaxy from launching a low-cost version of Lipitor in Nov, expected to bring $550-600...
- Pfizer faces US probe, to pay $2.3 bnPfizer will pay $2.3 bn to settle a US investigation into illegal marketing of medicines, the largest agreement in such a case, and a subsi...
- Pfizer’s Q3 profit up on downsizing, higher salesPfizer, the world’s biggest drugmaker, said profit tripled because of higher sales of the pain pill Lyrica and lower costs from the 11,000 ...
- Ranbaxy, Pfizer settle Lipitor litigation worldwideRanbaxy has settled most of its patent disputes with Pfizer, allowing it to launch a generic version of Lipitor from November 30, 2011. Ran...
- Ranbaxy can advance Lipitor in AustraliaIn A mixed verdict for Ranbaxy Laboratories in its ongoing battle to launch a generic version of anti-cholesterol drug Lipitor, a full fede...
- Partial win for Ranbaxy in Lipitor caseIn a partial victory for Ranbaxy Laboratories in its patent litigation against Pfizer, an Australian court has ruled in the Indian company'...
- Pfizer again sues Ranbaxy over LipitorPfizer has filed two separate patent infringement cases against Ranbaxy in a bid to extend the exclusivity of its $13-billion anti-choleste...
Load More
